#AdComms - Twitter Hashtag

about 1 year ago

Hands-On DAS Training for Safer Rail Tunnels Vincent Brown, Senior Technical Support Desk #Engineer at #PBEAxell joined the team at ADComms’ Technical Training Facility in #Scunthorpe to deliver a hands-on training session for Network #Rail staff #PBEAxell #ADComms l

AxellPbe's tweet photo. Hands-On DAS Training for Safer Rail Tunnels

Vincent Brown, Senior Technical Support Desk #Engineer at #PBEAxell joined the team at ADComms’ Technical Training Facility in #Scunthorpe to deliver a hands-on training session for Network #Rail staff

#PBEAxell #ADComms l https://t.co/9n19kzFj5f

0

3

1

0

45

Yale CRRIT @Yale_CRRIT

almost 2 years ago

@US_FDA @FDA Just yesterday, senior @US_FDA officials published a statement on #AdComms, reiterating their importance. But their plans to optimize #AdComm use remain vague. See below ⬇️ https://t.co/ZBLWvYJYY1

Yale_CRRIT's tweet photo. @US_FDA @FDA Just yesterday, senior @US_FDA officials published a statement on #AdComms, reiterating their importance. But their plans to optimize #AdComm use remain vague.

See below ⬇️
https://t.co/ZBLWvYJYY1 https://t.co/sbgvuPSOTe

1

2

0

68

Yale CRRIT @Yale_CRRIT

almost 2 years ago

@US_FDA In light of recent, though few, controversial @FDA approvals that deviated from #AdComm recommendations, the agency announced efforts to reform #AdComms.

1

2

0

60

Yale CRRIT @Yale_CRRIT

almost 2 years ago

@US_FDA regularly convenes advisory committees (#AdComms), panels of outside experts, who provide recommendations on the agency’s regulatory decisions, including scientific questions, safety actions, and individual product approvals.

1

2

0

70

Yale CRRIT @Yale_CRRIT

almost 2 years ago

🚨Out today in @JAMANetworkOpen, 🚨 @nikchaudhry_ & the team examine temporary member participation in @US_FDA #AdComms—their voting recommendations & concordance with FDA regulatory decisions. Read our synopsis in the thread below. 📜 Link: https://t.co/Ul6LJZM63I

Yale_CRRIT's tweet photo. 🚨Out today in @JAMANetworkOpen, 🚨 @nikchaudhry_ & the team examine temporary member participation in @US_FDA #AdComms—their voting recommendations & concordance with FDA regulatory decisions.

Read our synopsis in the thread below.

📜 Link: https://t.co/Ul6LJZM63I https://t.co/cCpv8NiUD3

1

12

5

3

2K

Sam Armitage @SamArmitage304

over 2 years ago

Honour to be a part of @ADStockport’s launch game this afternoon, as Stockport won a record 11th game in a row (10 in the league) against a struggling Tranmere side. Still a long way to go, but this Stockport side should be settling in the top 3 this season #adcomms #efl #scfc

SamArmitage304's tweet photo. Honour to be a part of @ADStockport’s launch game this afternoon, as Stockport won a record 11th game in a row (10 in the league) against a struggling Tranmere side. Still a long way to go, but this Stockport side should be settling in the top 3 this season #adcomms #efl #scfc https://t.co/RSYylmup5k

0

9

1

0

551

BiopharmIQ by Amp

@BiopharmIQ

over 3 years ago

Congrats $ACAD on FDA approval! #PDUFAs & #AdComms on deck $CDTX 3/22 Rezafungin - Fungal infections - PDUFA $IONS 3/22 Tofersen - ALS - Adcomm $BIIB 3/22 067 - ALS - Adcomm $INCY Ruxolitinib - myelofibrisis - PDUFA Check out our #PDUFA calendar https://t.co/JuOCWEkNC4

BiopharmIQ by Amp

@BiopharmIQ

over 3 years ago

👏 Congrats to $ACAD, its investors, & Rett Syndrome patients on approval of DAYBUE (Trofinetide) for the treatment of Rett Syndrome • Rare genetic disease • 1st approved drug • Supported by Phase 3 Lavender trial data. • No Black Box warning on label • Nice stock runup to approval ~33% • BPIQ Big Mover event • ACAD gets FDA rare pediatric disease voucher • Value ~$100M Competitors from BPIQ Company Screener: $TSHA $AVXL $JAZZ #PDUFA #Rettsyndrome https://t.co/0uRns3GsVt

0

8

2

0

3K

0

7

0

1

6K

eyeonfda @eyeonfda

over 3 years ago

My overview of #AdComms held last year by @US_FDA compared to previous years - there have been fewer held and they have skewed more negatively. Is it be a difference pre-/post-pandemic? Does the shift to a virtual setting make a difference? https://t.co/cwL3ydA6kV #pharma

0

1

2

0

294

eyeonfda @eyeonfda

over 6 years ago

The #COVID19 impact on #FDA drug approvals, #AdComms and workflow in a Q&A with #CDER - https://t.co/DlyyIKNzfO #coronavirus #pharma

0

1

0

SAC Tracker @FDAadcomm

almost 8 years ago

ICYMI, US #FDA convenes 3 #AdComms this week: Links to briefing documents: 1) Wed - Proposed #Rituxan biosimilar by Celltrion ( $RHHBY) https://t.co/U24d05SPiB 2) Thur - $TRVN #oliceridine https://t.co/7KZkPKKxzj 3) Fri - $ACRX #sufentanil (see #2. Documents should post tomorrow)

SAC Tracker @FDAadcomm

almost 8 years ago

US FDA convenes 3 AdComms this week: 1) Celltrion's biosimilar of $RHHBY's Rituxan (rituximab)- https://t.co/2608OeVm9t; 2) $TRVN's #olicerdiine (#opioid) - https://t.co/0EXQ7h6Bp1; and 3) $ACRX's #sufentanil (#opioid)- https://t.co/cXqI2apqh1.